1 / 6

ULTRAVIOLET LIGHT C IN THE TREATMENT OF DIABETIC ULCERS AND CHRONIC WOUNDS WITH MRSA

ULTRAVIOLET LIGHT C IN THE TREATMENT OF DIABETIC ULCERS AND CHRONIC WOUNDS WITH MRSA. THE TREATMENT.

calla
Download Presentation

ULTRAVIOLET LIGHT C IN THE TREATMENT OF DIABETIC ULCERS AND CHRONIC WOUNDS WITH MRSA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ULTRAVIOLET LIGHT C IN THE TREATMENT OF DIABETIC ULCERS AND CHRONIC WOUNDS WITH MRSA THE TREATMENT The prevalence of antibiotic-resistant bacteria such as methicillin-resistant Staphylococcus aureus is rapidly increasing in healthcare facilities and spreading to the community. Methicillin-resistant S. aureus colonize the skin and open wounds and can interfere with wound healing. Recent studies have shown that ultraviolet light C can kill antibiotic-resistant strains of bacteria such as methicillin-resistant S. aureus in both laboratory cultures and animal tissue. This clinical report describes the effects of ultraviolet light C on wound bioburden and closure in people with chronic ulcers infected with methicillin-resistant S. aureus.. This case studies also suggests that ultraviolet light C is a promising adjunctive therapy for chronic wounds containing antibiotic-resistant bacteria such as methicillin-resistant S. aureus.

  2. KEY POINTS • Create a bacteria-free environment to treat Decubitus ulcers. • Create an environment to enhance the healing and prevent future infection. • Sanitize linens and other material coming in contact with the wound. • Destroy pathogens rather than permitting mutation to more difficult drug resistant bacteria. • The SM2020 has proven to be 99.9% kill rate effective for the methicillin-resistant strain of S. aureus (MRSA) after 90 seconds treatment. The kill rate reaches 100% effectiveness after 180 seconds. • For vancomycin resistant E. faecalis (VRE) the SM2020 was 99.9% effective at 45 seconds and 100% effective @ 90 seconds.

  3. THE EQUIPMENT SM2020 – CUSTOMIZED MEDICAL GERMICIDAL ULTRAVIOLET SANITIZING SYSTEM UVC TREATMENT PROTOCOL Using an application technique that has been prescribed by Nussbaum et.al, our UVmax SM2020 UVC is applied at a distance of 9” vertically above the wound using pre measured and customized fittings. Before treatment, the customized UVmax SM2020 with a 253.7 nm hot cathode UVC double tube lamps and generator is warmed up for 5 minutes before being placed above the wound. The ulcer is to be cleaned with sterile saline, and a layer of petroleum jelly is applied to the surrounding periulcer skin and any healthy granulation tissue. The wound edges are to be covered with a drape. The UVmax SM2020 sanitizing system then is placed above the wound at 180 sec per wound site at a distance of 9”. This length of time is recommended for the treatment of infected ulcers and was selected based on MRSA killing rates reported in the in vitro study. Subsequent and further periodic treatment is based on the recommendation of the physician or specialist in attendance.

  4. THE SPECIFICATION

  5. TREATMENT RESULTS

  6. SOMA Medical Sdn Bhd (671166-M) No. 2-4-2, 4th Floor Menara KLH Business Centre 2nd Mile Off Jalan Ipoh 51200 Kuala Lumpur West Malaysia Tel: 603-2381 0581 / 0553 Fax: 603-2381 0351 Email:somamedical@gmail.com Website:www.somamedical.net Thank You

More Related